111, Inc. (YI)
NASDAQ: YI · Real-Time Price · USD
5.76
+0.76 (15.20%)
At close: Jan 14, 2026, 4:00 PM EST
5.65
-0.11 (-1.91%)
After-hours: Jan 14, 2026, 7:40 PM EST
111, Inc. Market Cap
111, Inc. has a market cap or net worth of $49.92 million as of January 14, 2026. Its market cap has decreased by -21.26% in one year.
Market Cap
49.92M
Enterprise Value
9.35M
1-Year Change
-21.26%
Ranking
Category
Stock Price
$5.76
Market Cap Chart
Since September 12, 2018, 111, Inc.'s market cap has decreased from $1.11B to $49.92M, a decrease of -95.52%. That is a compound annual growth rate of -34.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 43.34M | 95.31% |
| Dec 31, 2025 | 22.19M | -58.42% |
| Dec 31, 2024 | 53.37M | -59.01% |
| Dec 29, 2023 | 130.19M | -48.23% |
| Dec 30, 2022 | 251.48M | -13.30% |
| Dec 31, 2021 | 290.06M | -49.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |